<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01879774</url>
  </required_header>
  <id_info>
    <org_study_id>002</org_study_id>
    <nct_id>NCT01879774</nct_id>
  </id_info>
  <brief_title>Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia</brief_title>
  <official_title>Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this epidemiological study is to characterize the neuropsychological and motoric
      performance in patients with hyponatremia. Newer studies revealed an association between mild
      hyponatremia and unstable walking, frequency of falls and risk of a fracture, questioning the
      paradigm of an &quot;asymptomatic&quot; hyponatremia. Until now, there is no known detailed
      investigation and characterisation of the cognitive and motoric performance or limitation by
      this disorder. Therefore this study will investigate patients with hyponatremia on the basis
      of neuropsychological and neurological tests.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyponatremia is the most common electrolyte disorder in outpatients and hospitalized
      patients. The prevalence of hospital-associated hyponatremia is estimated to be up to 40%.
      Especially mild to moderate hyponatremia (125-136 mmo/l) without apparent symptoms has
      seldomly been accurately assessed but rather seen as clinically irrelevant. Cognitive
      limitations, unstable gait and motoric disorders as well as depressive conditions were
      described in smaller studies and single case reports.

      In terms of the question, if a therapeutic influence is also reasonable in slight symptomatic
      hyponatremia it is necessary to establish an accurate phenotyping of patients with
      hyponatremia, which quantifies the individual cognitive, motoric and psychological qualities.

      Patients with hyponatremia will be examined on the basis of standardized neuropsychological
      and neurological tests. Following questions are to be answered with this study:

        1. Which cognitive, motoric and psychological functions are impaired due to hyponatremia?

        2. Is there a correlation between the extend of hyponatremia and the different test
           results?

        3. Is there an intraindividual difference in test results during hyponatremia and normal
           sodium concentrations?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2012</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of Performance in individual tests</measure>
    <time_frame>Change in individual tests at Baseline and at the earliest 48 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hyponatremia</condition>
  <arm_group>
    <arm_group_label>Patients with hyponatremia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Neuropsychological and motoric tests are conducted in patients with hyponatremia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with normal serum sodium</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Neuropsychological and motoric tests are conducted in patients with normal serum sodium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological and motoric tests</intervention_name>
    <description>Neuropsychological tests
Mini Mental Status Test
Dem-Tect
Rey-Osterrieth Complex Figure Test
Trailmaking Test
Beck Depression Inventory
d2-R (optional)
Motoric tests
modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
Timed-up-and-go Test
Halstead Fingertapping Test
AIMS (Abnormal involuntary movement scale)
EEG (only in patients with hyponatremia)
MRI (only in patients with hyponatremia)</description>
    <arm_group_label>Patients with hyponatremia</arm_group_label>
    <arm_group_label>Patients with normal serum sodium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women 18 years of age or older

          -  Hyponatremia with serum sodium &lt; 130 mmol/l

          -  Men and women with normal serum sodium &gt; 130 mmol/l (control group)

        Exclusion Criteria:

          -  traumatic cerebral injury, hemorrhagic and ischemic insult as cause of hyponatremia

          -  professional or private relationship between subject and the investigators, or
             dependance on the investigators

          -  Placement in an institution based on official orders

          -  Patients who are unable to give informed consent

          -  Patients with contraindication for MRI investigation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volker Burst, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Volker Burst, MD</last_name>
    <phone>+49 221 478 86285</phone>
    <email>volker.burst@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cornelia Boehme</last_name>
    <email>cornelia.boehme@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Volker Burst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Torsten Kubacki, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Witthus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franziska Grundmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victor Suarez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Mario Serio</name>
      <address>
        <city>Firenze</city>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Peri, Associate Professor</last_name>
    </contact>
    <investigator>
      <last_name>Alessandro Peri, Associate Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 23, 2013</study_first_submitted>
  <study_first_submitted_qc>June 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2013</study_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Volker Burst</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hyponatremia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

